|
SUPT16H expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.919000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.188400E-01 |
| Normal-vs-Stage2 |
1.611430E-01 |
| Normal-vs-Stage3 |
4.405400E-01 |
| Normal-vs-Stage4 |
9.043800E-01 |
| Stage1-vs-Stage2 |
4.949800E-01 |
| Stage1-vs-Stage3 |
1.742180E-01 |
| Stage1-vs-Stage4 |
6.311200E-01 |
| Stage2-vs-Stage3 |
1.026190E-01 |
| Stage2-vs-Stage4 |
3.414200E-01 |
| Stage3-vs-Stage4 |
7.231800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.138000E-01 |
| Normal-vs-AfricanAmerican |
8.996800E-01 |
| Normal-vs-Asian |
3.974600E-01 |
| Caucasian-vs-AfricanAmerican |
7.602600E-01 |
| Caucasian-vs-Asian |
4.611400E-01 |
| AfricanAmerican-vs-Asian |
4.887200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.403000E-01 |
| Normal-vs-Female |
2.661400E-01 |
| Male-vs-Female |
4.918000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.851400E-01 |
| Normal-vs-Extreme_Weight |
2.382400E-01 |
| Normal-vs-Obese |
3.799800E-01 |
| Normal-vs-Extreme_Obese |
7.416000E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.133800E-01 |
| Normal_Weight-vs-Obese |
3.931400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.910800E-01 |
| Extreme_Weight-vs-Obese |
6.375800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.747600E-01 |
| Obese-vs-Extreme_Obese |
2.753800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.510580E-01 |
| Normal-vs-Age(41-60Yrs) |
5.299600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.468230E-01 |
| Normal-vs-Age(81-100Yrs) |
5.604500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.070800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.843500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.441800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.012100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.223900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.046400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.694000E-01 |
| Normal-VS-Type2 PRCC |
2.583900E-02 |
| Normal-VS-KIRP CIMP |
2.253600E-01 |
| Normal-VS-Unclassified PRCC |
6.337000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.898500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.326600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.784800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.917600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.165000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.857400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.461500E-02 |
| Normal-vs-N1 |
5.022200E-02 |
| Normal-vs-N2 |
8.360200E-03 |
| N0-vs-N1 |
3.399200E-03 |
| N0-vs-N2 |
3.979400E-03 |
| N1-vs-N2 |
4.49900000000225E-05 |
|
|
